The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...
Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...
Novartis, a leading innovative medicines company, and the National Football League (NFL) announced an unprecedented partnership that names Novartis as the official first-in-category corporate ...
The NFL have signed its first-ever pharmaceutical partner in a multi-year deal with Novartis to focus on the NFL’s health ...
Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home ...
Novartis is not panicking about higher tariffs on pharmaceutical imports that U.S. President Donald Trump could impose, the ...
The NFL has inked a multi-year deal with pharmaceutical giant Novartis, marking its first such partnership. This ...
Legend Biotech is building a new $150 million manufacturing plant, with its partner Johnson & Johnson, with the goal of ...
Novartis AG (NYSE:NVS – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors acquired 54,767 call options on the stock. This represents an increase of 2,389% ...
Swiss pharmaceutical company Novartis has renewed its 15,865-square-foot office at Property & Building Corporation’s 10 ...
Under the terms of the agreement, Kyorin will receive $55m upfront and will be eligible for milestone payments of up to ...
ZURICH, March 6 (Reuters) - Novartis (NOVN.S), opens new tab is not panicking about higher tariffs on pharmaceutical imports that U.S. President Donald Trump could impose, the drug maker's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results